StonvexLoading…
StonvexStonvexStonvexCore line items from RVTY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-05 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $711.12M | $2.86B | $2.08B | $1.39B |
Operating Income | $75.89M | $356.63M | $244.89M | $162.99M |
Net Income | $40.72M | $241.20M | $142.84M | $53.95M |
EPS (Diluted) | $0.36 | $2.07 | $1.21 | $0.81 |
Total Assets | $12.00B | $12.17B | $12.14B | $12.36B |
Total Liabilities | $4.81B | $4.92B | $4.76B | $4.81B |
Cash & Equivalents | $860.32M | $919.86M | $931.39M | $991.85M |
Free Cash Flow OCF − CapEx | $95.45M | $509.41M | $347.62M | $227.62M |
Shares Outstanding | 111.63M | 112.28M | 114.03M | 116.33M |